Formulations for lysosomal enzymes
US8785168B2 · kind B2 · utility
30Cited by
71References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 17, 2010 |
| Grant date | Jul 22, 2014 |
| Priority date | — |
| Expiry date | Dec 16, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides improved formulations for lysosomal enzymes useful for enzyme replacement therapy. Among other things, the present invention provides formulations that preserve or enhance the stability and/or efficacy of a lysosomal enzyme such as acid alpha-glucosidase.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.